Mary C. Clouser

Phase III Trial of Ursodeoxycholic Acid To Prevent Colorectal Adenoma Recurrence

David S. Alberts, Marı́a Elena Martı́nez, Lisa M. Hess et al. · JNCI Journal of the National Cancer Institute · 2005 · 248 citations · Full text

Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival

David S. Alberts, Christian Marth, Ronald D. Alvarez et al. · Gynecologic Oncology · 2008 · 128 citations

Progression-free Survival, Medicine, Cancer Management +8

Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)

David S. Alberts, Pengfei Liu, Sharon P. Wilczynski et al. · Gynecologic Oncology · 2007 · 117 citations · Full text

Medicine, Metronomic Therapy, Gynecology +9

Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)

David S. Alberts, P. Y. Liu, Sharon P. Wilczynski et al. · International Journal of Gynecological Cancer · 2007 · 69 citations

Effect of non‐steroidal anti‐inflammatory drugs on non‐melanoma skin cancer incidence in the SKICAP‐AK trial

Mary C. Clouser, Denise J. Roe, Janet A. Foote et al. · Pharmacoepidemiology and Drug Safety · 2009 · 64 citations